Exelixis Inc.EXEL
Close of Friday, October 23, 2026 · Exelixis Inc. is trading above its Pivot, OnlyAlpha's long-term trend line.
Price
$64.53
vs its Pivot
+28.1%
OnlyAlpha Score
78
Trend
Above its Pivot
Last 12 months. Solid line: price. Dashed green: the Pivot. ▲ closed at least 1% above the Pivot (in) · ▼ closed below it (out). Hover or drag across the chart for any day.
Returns
| 1 month | Year to date | 1 year | 3 years / yr | 5 years / yr |
|---|---|---|---|---|
| +11.4% | +47.2% | +78.9% | — | — |
No dividend in the last 12 months.
Who runs and owns it
In these funds
IBB · 1.00%IYH · 0.23%IYY · 0.02%IJH · 0.00%
Big investors that own it (latest 13F)
| Renaissance Technologies founded by Jim Simons | 1.0% of holdings |
Members of Congress who traded it
| Donna E. Shalala D · FL | 2 buys · 2 sells · last sell 2019-06-04 |
| Ro Khanna D · CA | 0 buys · 1 sells · last sell 2024-01-10 |
Suppliers, customers and partners
EXEL sells to
| Ipsen | cabozantinib royalties $837.9M cumulative |
| Takeda | cabozantinib royalties $60.3M cumulative |
From the companies' own annual reports filed with the SEC.
Healthcare · Biotech
Get EXEL in your free daily emailAfter every close: whether EXEL is above or below its Pivot, its OnlyAlpha Score, and any new buy or sell signal, along with the rest of your list.
Track EXEL free → Full Stock check
Track EXEL free → Full Stock check